Lidocaine Infusion for Propofol Dose Reduction in ERCP Procedure

• Status: Recruiting
• Trial end date: 2022-04-03
• Target enrollment: 0
• Participant gender: All

Summary

This study aims to investigate the dose reduction of propofol if associated with continuous infusion of lidocaine during ERCP procedures in patients over 65 years old.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Iuliu Hatieganu University of Medicine and Pharmacy
• Treatments: Lidocaine

Criteria

Inclusion Criteria:

• 65-85 years old

• physical status ASA I, II, III,

• ERCP scheduled

Exclusion Criteria:

• ASA IV or higher

• severe renal, cardiac or liver failure,

• allergy to lidocaine,

• patients weighing less than 40 kg,

• inability to give informed consent